framycetin has been researched along with linezolid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
| Di Giorgio, A; Duca, M; Tran, TP; Vo, DD | 1 |
| Xu, Z | 1 |
| Hyun, S; Jeong, S; Kwon, M; Lee, J; Lee, KH; Shin, KJ; Yu, J | 1 |
| Kim, HJ; Kwon, M; Yu, J | 1 |
1 review(s) available for framycetin and linezolid
| Article | Year |
|---|---|
1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Anti-Bacterial Agents; Drug Design; Methicillin-Resistant Staphylococcus aureus; Triazoles | 2020 |
4 other study(ies) available for framycetin and linezolid
| Article | Year |
|---|---|
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; DEAD-box RNA Helicases; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Models, Molecular; Molecular Sequence Data; Neoplasms; Ribonuclease III; Ribosomes; Tetracyclines | 2015 |
An approach to enhance specificity against RNA targets using heteroconjugates of aminoglycosides and chloramphenicol (or linezolid).
Topics: Acetamides; Aminoglycosides; Chloramphenicol; Framycetin; Linezolid; Nucleic Acid Conformation; Oxazolidinones; RNA; Structure-Activity Relationship; Substrate Specificity | 2004 |
Elucidation of the RNA target of linezolid by using a linezolid-neomycin B heteroconjugate and genomic SELEX.
Topics: Acetamides; Base Sequence; Binding Sites; Biotin; Drug Delivery Systems; Escherichia coli; Framycetin; Linezolid; Molecular Sequence Data; Molecular Structure; Oxazolidinones; Protein Synthesis Inhibitors; RNA Probes; SELEX Aptamer Technique | 2007 |